SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...
Despite the U.S. government shutdown, the Education Department will continue to process the FAFSA. If it's your first time ...
The West Virginia Mountaineers and UCF Knights will fight Saturday afternoon for their first Big 12 Conference win this ...
MedPage Today on MSN
First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer
BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
Given the intricate nature of these technologies, enforcing detailed, granular standards throughout the development lifecycle ...
Third Quarter 2025 HighlightsNet income for the third quarter of 2025 was $9.7 million, compared to $10.4 million in the prior quarter and $9.5 ...
Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Graduates of the Adult Practical Nursing Program at Schuylkill Technology Center North achieved an outstanding rating on the National Council Licensure Examination, officials announced. The 24 ...
Ranging in age from a tender 25 to a seasoned 39, this year’s GenNext Awards honorees work in a range of disciplines at a ...
Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, ...
Across Long Island, homeowners are finding creative ways to make the most of every square foot. The latest interior design trend centers on transforming overlooked corners into purposeful spaces that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results